Group aims to develop guidelines to improve test naming | Safety, effectiveness of A1C testing kits for home-use | Researchers develop low-cost COVID-19 test
Ila Singh, chief of laboratory medicine and pathology informatics at Texas Children's Hospital in Houston, along with a coalition of clinicians, pathologists, reference laboratories, professional organizations and accreditation agencies have created a nonprofit group called the Test Renaming for Understanding and Utilization for Laboratory Test Names, or TRUU-Lab, which aims to develop guidelines to improve test naming to prevent clinicians from ordering unnecessary or incorrect tests.
Strategies and solutions for clinicians and health care leaders The pandemic, a summer of protests against injustice, an increasing focus on social determinants of health and the adoption of value-based care have made addressing health inequity an imperative. Join SmartBrief and a panel of experts from across health care for a virtual roundtable discussion of health equity challenges and solutions.
A study in the journal Diabetes Technology & Therapeutics found that a measurement of A1C with capillary blood collection kits for home-use yielded similar accuracy as a measurement with venous blood draw. The researchers say the findings could be beneficial for those who require home A1C testing kits, especially for children for whom a venous blood draw can be painful and challenging.
Online Graduate Programs Designed for Your Career Drexel's online programs in biomedicine, clinical research, drug discovery, infectious disease, immunology, and molecular medicine were developed to provide you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more
Researchers from the Wageningen University in the Netherlands have developed the CoroNaspresso, a low-cost point-of-care COVID-19 test made from coffee capsules.
Researchers from the Walter Reed Army Institute for Research have developed an assay that can detect cathepsin B in blood. "This would allow for early, accurate detection as well as monitoring of injury or disease," said Angela Boutte, one of the researchers.
House lawmakers voted 384-38 to pass a bill that would delay 2% Medicare payment cuts for health care providers until year-end. The legislation now heads to President Joe Biden for his expected signature.
The US will allocate $1.7 billion to facilitate detection, monitoring and mitigation of emerging and potentially more infectious coronavirus variants, according to the Biden administration. About half of current US cases involve variant forms of the virus, a figure that "underscores the critical need for rapid and ongoing genomic surveillance," said CDC Director Rochelle Walensky.
European regulators have give CE mark approval to Ortho Clinical Diagnostics for its Vitros SARS-CoV-2 Antigen Test, allowing for a more convenient sample collection and expanded viral transport media.
AACC is searching for the next innovative technology in the field of laboratory medicine. AACC encourages applicants to submit proposals showcasing AI (Artificial Intelligence) and ML (Machine Learning) technologies in addition to other innovative and disruptive diagnostic solutions. The winning team will receive AACC coverage and the opportunity to present its technology at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo. Don’t let COVID-19 stop you from submitting! There will be virtual presentation options for those who are unable to travel. Applications accepted until April 28.
Invest in the professional development of your laboratory team by enrolling 5 or more staff members in a certificate program and receive up to 75% off. AACC will help you create a customized learning package that will keep your staff at the top of their careers.
